Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-6148
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone ; volume:4 ; number:1 ; day:13 ; month:8 ; year:2008 ; pages:1-8 ; date:12.2008
BMC veterinary research ; 4, Heft 1 (13.8.2008), 1-8, 12.2008
- Creator
-
Webster, Joshua D.
- Contributor
-
Yuzbasiyan-Gurkan, Vilma
Thamm, Douglas H.
Hamilton, Elizabeth
Kiupel, Matti
SpringerLink (Online service)
- DOI
-
10.1186/1746-6148-4-32
- URN
-
urn:nbn:de:1111-2016080545520
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Webster, Joshua D.
- Yuzbasiyan-Gurkan, Vilma
- Thamm, Douglas H.
- Hamilton, Elizabeth
- Kiupel, Matti
- SpringerLink (Online service)
Other Objects (12)
Prognostic significance of YKL-40 expression in canine cutaneous mast cell tumors
Microvessel density is as a prognostic factor in canine cutaneous mast cell tumors
CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers
Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy
Prognostic factors in canine appendicular osteosarcoma – a meta-analysis
Interleukin-2 receptor expression in canine cutaneous mast cell tumors
Interleukin-2 Receptor Expression in Canine Cutaneous Mast Cell Tumors
CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes
Gene expression profiling based identifications of potential prognostic molecular markers in decitabine treated acute myeloid leukemia
Serum Prealbumin Levels on Admission as a Prognostic Marker in Stroke Patients Treated with Mechanical Thrombectomy
Prognostic significance of YKL-40 expression in canine cutaneous mast cell tumors
Microvessel density is as a prognostic factor in canine cutaneous mast cell tumors
CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers
Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy
Prognostic factors in canine appendicular osteosarcoma – a meta-analysis
Interleukin-2 receptor expression in canine cutaneous mast cell tumors
Interleukin-2 Receptor Expression in Canine Cutaneous Mast Cell Tumors
CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes
Gene expression profiling based identifications of potential prognostic molecular markers in decitabine treated acute myeloid leukemia
Serum Prealbumin Levels on Admission as a Prognostic Marker in Stroke Patients Treated with Mechanical Thrombectomy
Prognostic significance of YKL-40 expression in canine cutaneous mast cell tumors
Microvessel density is as a prognostic factor in canine cutaneous mast cell tumors
CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers
Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy
Prognostic factors in canine appendicular osteosarcoma – a meta-analysis
Interleukin-2 receptor expression in canine cutaneous mast cell tumors
Interleukin-2 Receptor Expression in Canine Cutaneous Mast Cell Tumors
CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes
Gene expression profiling based identifications of potential prognostic molecular markers in decitabine treated acute myeloid leukemia